Zobrazeno 1 - 10
of 2 460
pro vyhledávání: '"C. Formenti"'
Publikováno v:
Il Foro Italiano, 2013 May 01. 136(5), 1647/1648-1653/1654.
Externí odkaz:
https://www.jstor.org/stable/23730400
Autor:
Viozzi, Gualtiero
Publikováno v:
Il Foro Italiano, 1970 Jun 01. 93(6), 1755/1756-1759/1760.
Externí odkaz:
https://www.jstor.org/stable/23160774
Publikováno v:
Il Foro Italiano, 1970 Jun 01. 93(6), 1607/1608-1613/1614.
Externí odkaz:
https://www.jstor.org/stable/23160737
Publikováno v:
Il Foro Italiano, 1970 Feb 01. 93(2), 415/416-419/420.
Externí odkaz:
https://www.jstor.org/stable/23160086
Autor:
Scialoja, Antonio
Publikováno v:
Il Foro Italiano, 1905 Jan 01. 30, 1379/1380-1391/1392.
Externí odkaz:
https://www.jstor.org/stable/23107833
Publikováno v:
Il Foro Italiano, 1935 Jan 01. 60, 1083/1084-1085/1086.
Externí odkaz:
https://www.jstor.org/stable/23130496
Publikováno v:
Il Foro Italiano, 1876 Jan 01. 1, 215/216-217/218.
Externí odkaz:
https://www.jstor.org/stable/23083150
Autor:
Nasser K. Altorki, Zachary H. Walsh, Johannes C. Melms, Jeffery L. Port, Benjamin E. Lee, Abu Nasar, Cathy Spinelli, Lindsay Caprio, Meri Rogava, Patricia Ho, Paul J. Christos, Ashish Saxena, Olivier Elemento, Bhavneet Bhinder, Casey Ager, Amit Dipak Amin, Nicholas J. Sanfilippo, Vivek Mittal, Alain C. Borczuk, Silvia C. Formenti, Benjamin Izar, Timothy E. McGraw
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-14 (2023)
Abstract We previously reported the results of a randomized phase II trial (NCT02904954) in patients with early-stage non-small cell lung cancer (NSCLC) who were treated with either two preoperative cycles of the anti-PD-L1 antibody durvalumab alone
Externí odkaz:
https://doaj.org/article/9c53c31942514d7386ef3822fb6b7bc0
Autor:
Ariel E. Marciscano, Sydney Wolfe, Xi Kathy Zhou, Christopher E. Barbieri, Silvia C. Formenti, Jim C. Hu, Ana M. Molina, David M. Nanus, Jones T. Nauseef, Douglas S. Scherr, Cora N. Sternberg, Scott T. Tagawa, Himanshu Nagar
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background Ultra-hypofractionated image-guided stereotactic body radiotherapy (SBRT) is increasingly used for definitive treatment of localized prostate cancer. Magnetic resonance imaging-guided radiotherapy (MRgRT) facilitates improved visu
Externí odkaz:
https://doaj.org/article/fa243c6550cd4849bd0e24f9ff480799
Autor:
Nils-Petter Rudqvist, Maud Charpentier, Claire Lhuillier, Erik Wennerberg, Sheila Spada, Caroline Sheridan, Xi Kathy Zhou, Tuo Zhang, Silvia C. Formenti, Jennifer S. Sims, Alicia Alonso, Sandra Demaria
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-23 (2023)
Abstract Radiation therapy (RT) increases tumor response to CTLA-4 inhibition (CTLA4i) in mice and in some patients, yet deep responses are rare. To identify rational combinations of immunotherapy to improve responses we use models of triple negative
Externí odkaz:
https://doaj.org/article/af928465d9fd4bf593326b1e0448f794